» Articles » PMID: 19732156

The Molecular and Cellular Basis of Pathogenesis in Melioidosis: How Does Burkholderia Pseudomallei Cause Disease?

Overview
Specialty Microbiology
Date 2009 Sep 8
PMID 19732156
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Melioidosis, a febrile illness with disease states ranging from acute pneumonia or septicaemia to chronic abscesses, was first documented by Whitmore & Krishnaswami (1912). The causative agent, Burkholderia pseudomallei, was subsequently identified as a motile, gram-negative bacillus, which is principally an environmental saprophyte. Melioidosis has become an increasingly important disease in endemic areas such as northern Thailand and Australia (Currie et al., 2000). This health burden, plus the classification of B. pseudomallei as a category B biological agent (Rotz et al., 2002), has resulted in an escalation of research interest. This review focuses on the molecular and cellular basis of pathogenesis in melioidosis, with a comprehensive overview of the current knowledge on how B. pseudomallei can cause disease. The process of B. pseudomallei movement from the environmental reservoir to attachment and invasion of epithelial and macrophage cells and the subsequent intracellular survival and spread is outlined. Furthermore, the diverse assortment of virulence factors that allow B. pseudomallei to become an effective opportunistic pathogen, as well as to avoid or subvert the host immune response, is discussed. With the recent increase in genomic and molecular studies, the current understanding of the infection process of melioidosis has increased substantially, yet, much still remains to be elucidated.

Citing Articles

A Novel Virulent Clinical Isolate of Burkholderia pseudomallei Imported from Thailand Exhibiting Resistance to Trimethoprim-Sulfamethoxazole.

Amit S, Gur D, Aftalion M, Biber A, David P, Cohen-Gihon I Am J Trop Med Hyg. 2024; 112(1):116-123.

PMID: 39437772 PMC: 11720787. DOI: 10.4269/ajtmh.24-0231.


Genome sequence of two novel virulent clinical strains of Burkholderia pseudomallei isolated from acute melioidosis cases imported to Israel from India and Thailand.

Cohen-Gihon I, Zaide G, Amit S, Zohar I, Schwartz O, Maor Y BMC Genom Data. 2024; 25(1):47.

PMID: 38783201 PMC: 11118722. DOI: 10.1186/s12863-024-01225-x.


Function of Burkholderia pseudomallei RpoS and RpoN2 in bacterial invasion, intracellular survival, and multinucleated giant cell formation in mouse macrophage cell line.

Diep D, Vong L, Tungpradabkul S Antonie Van Leeuwenhoek. 2024; 117(1):39.

PMID: 38388985 DOI: 10.1007/s10482-024-01944-2.


Assessment of CD200R Activation in Combination with Doxycycline in a Model of Melioidosis.

Thom R, Williamson E, Casulli J, Butcher W, Burgess G, Laws T Microbiol Spectr. 2023; 11(3):e0401622.

PMID: 37199641 PMC: 10269878. DOI: 10.1128/spectrum.04016-22.


Early Activation of iNKT Cells Increased Survival Time of BALB/c Mice in a Murine Model of Melioidosis.

Kasetthat T, Kamuthachad L, Sermswan R, Watarai H, Matangkasombut P, Wongratanacheewin S Infect Immun. 2022; 90(12):e0026822.

PMID: 36374098 PMC: 9753712. DOI: 10.1128/iai.00268-22.